Catheter-related Bloodstream Infection
📧 Sign up to get email alerts when something new happens for Catheter-related Bloodstream Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Biofilm-induced Antimicrobial Resistance RIsk ERadication in Critical Care Central Venous Catheters
This clinical trial investigates strategies to eradicate biofilm-associated antimicrobial resistance in critical-care central venous cathete…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Hydrogen Peroxide and Ultraviolet Light for Disinfecting Surfaces in Intensive Care Units [NA]
This clinical trial investigates using hydrogen peroxide and ultraviolet light to disinfect surfaces in intensive care units to reduce hospi…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Impact of Infusion Line Change Frequency on Infectious Complications Related to Central Venous Catheters in the ICU - A Randomized Controlled Trial [NA]
A randomized controlled trial is evaluating how often infusion lines are changed and its effect on catheter-related bloodstream infections i…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Chlorhexidine Caps for CLABSI Prevention in Hemodialysis: a Pilot Randomized Controlled Trial [NA]
A pilot randomized controlled trial is planned to assess the use of chlorhexidine-cap catheters for preventing infection in hemodialysis pat…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Investigational Study With the BD PosiFlush™ SafeScrub on NADs [NA]
This clinical trial updates an investigational study evaluating BD PosiFlush SafeScrub on NADs for preventing catheter-related bloodstream i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Efficacy of Taurolidine Containing Lock Solution for Prevention of Central Venous Catheter Infection in ICU Patients [NA]
This document reports on a completed clinical trial assessing the efficacy of a taurolidine-containing lock solution to prevent central veno…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Dialysis Catheter Caps Case Feasibility Study [NA]
Mayo Clinic-sponsored feasibility study evaluating dialysis catheter caps to prevent catheter-related bloodstream infections; the trial stat…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Analysis of Microbial Biofilms in Peripheral Venous Catheters and Their Implication in Infectious Risk
A clinical trial assessing how microbial biofilms form on peripheral venous catheters and what that means for infection risk, currently not …
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Recent Techniques for Diagnosing Central Venous Catheter-related Bloodstream Infections in Children [NA]
This clinical trial update summarizes recent diagnostic techniques for identifying catheter-related bloodstream infections in children; the …
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Multicenter Clinical Translational Study of "ICU-NO CRBSI" Based on Improvement Science [NA]
This multicenter translational study from Fudan University evaluates an ICU-based improvement-science intervention to prevent catheter-relat…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age [Phase 4]
Phase 4 open-label trial sponsored by CorMedix to assess safety and time to catheter-related bloodstream infections in pediatric patients fr…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Advanced Dressings for CVC Infection Prevention in PICU [NA]
A clinical trial evaluating advanced dressings to prevent catheter-related infections in pediatric ICU patients, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Risk Factors for Catheter-Related Bloodstream Infections in Hospitalized Intestinal Failure Patients
A completed clinical trial evaluating risk factors for catheter-related bloodstream infections in hospitalized patients with intestinal fail…
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: Effect of Use of Probiotics on Systemic Infection in Critically Ill Patients: a Double Blind, Randomized, Placebo-controlled Trial [NA]
A double-blind, randomized, placebo-controlled trial is evaluating whether probiotics reduce systemic infection in critically ill patients, …
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Antimicrobial Locks for Hemodialysis Catheter Infections [Phase 2]
Phase 2 clinical trial update reporting the completion of a study evaluating antimicrobial lock solutions to prevent catheter-related bloods…
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Staphylococcus Haemolyticus in the Neonatal Intensive Care Unit of CHSD in 2023: Analysis and Trends
A completed clinical trial analysis of Staphylococcus haemolyticus infections in newborns in NICUs, focusing on sepsis and catheter-related …
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Dressing Impregnated With Chlorhexidine and Vancomycin for the Prophylaxis of Central Venous Catheter-related Infections - a Randomized Trial [Phase 3]
A Phase 3 randomized trial evaluated a dressing impregnated with chlorhexidine and vancomycin to prevent central venous catheter-related inf…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Dalbavancin Versus Standard Antibiotic Therapy for Catheter-related Bloodstream Infections Due to Staphylococcus Aureus [Phase 3]
A Phase 3 trial is evaluating dalbavancin versus standard antibiotic therapy for catheter-related bloodstream infections caused by Staphyloc…
-
FDA approval · 2024-12-19FDA Approved: DEFENCATH — Supplemental Application (CorMedix Inc.)
FDA approved a supplemental application for Defencath, a taurolidine and heparin catheter-lock solution from CorMedix Inc., indicating regul…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Expanded Access Program for Patients At Risk for Catheter-related Infections Who Are Not Eligible for DefenCath® Clinical Trials
Expanded Access Program for patients at risk for catheter-related bloodstream infections who are not eligible for DefenCath clinical trials.
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: Clinical Trial Comparing TaurolockTMHep100 (Taurolidine 1.35%) and 0.9% Saline As Prevention of Recurrent Catheter-related Bloodstream Infections [NA]
A completed clinical trial comparing Taurolock Hep100 (taurolidine 1.35%) to 0.9% saline for preventing recurrent catheter-related bloodstre…
-
CLINICAL_TRIALS research · 2024-08-22Clinical Trial Update: Microorganisms on Reusable Tourniquets
Clinical trial update from Medical University of Gdansk on microbial colonization and infection risks associated with reusable tourniquets i…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: 8.4% Sodium Bicarbonate Locks in Intestinal Failure [Phase 2]
Phase 2 clinical trial update exploring 8.4% sodium bicarbonate locks for preventing catheter-related bloodstream infections in intestinal f…
-
FDA approval · 2023-11-15FDA Approved: DEFENCATH — Original Application (CorMedix Inc.)
Defencath is a taurolidine and heparin catheter-lock solution that received FDA approval via CorMedix's original NDA.
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: SQ53 Disinfectant Wipes for Prevention of CRBSI [NA]
Completed clinical trial evaluating SQ53 disinfectant wipes for prevention of catheter-related bloodstream infection.